Cited 9 times in 
Cited 8 times in 
Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Han, Eugene | - |
| dc.contributor.author | Huh, Ji Hye | - |
| dc.contributor.author | Lee, Eun Y. | - |
| dc.contributor.author | Bae, Ji C. | - |
| dc.contributor.author | Chun, Sung W. | - |
| dc.contributor.author | Yu, Sung H. | - |
| dc.contributor.author | Kwak, Soo H. | - |
| dc.contributor.author | Park, Kyong S. | - |
| dc.contributor.author | Lee, Byung Wan | - |
| dc.date.accessioned | 2022-05-09T17:01:14Z | - |
| dc.date.available | 2022-05-09T17:01:14Z | - |
| dc.date.created | 2022-05-24 | - |
| dc.date.issued | 2022-04 | - |
| dc.identifier.issn | 1462-8902 | - |
| dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/188336 | - |
| dc.description.abstract | [No abstract available] | - |
| dc.description.statementOfResponsibility | restriction | - |
| dc.language | English | - |
| dc.publisher | Wiley-Blackwell | - |
| dc.relation.isPartOf | Diabetes, Obesity and Metabolism | - |
| dc.relation.isPartOf | DIABETES OBESITY & METABOLISM | - |
| dc.rights | CC BY-NC-ND 2.0 KR | - |
| dc.title | Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial | - |
| dc.type | Article | - |
| dc.contributor.college | College of Medicine (의과대학) | - |
| dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
| dc.contributor.googleauthor | Han, Eugene | - |
| dc.contributor.googleauthor | Huh, Ji Hye | - |
| dc.contributor.googleauthor | Lee, Eun Y. | - |
| dc.contributor.googleauthor | Bae, Ji C. | - |
| dc.contributor.googleauthor | Chun, Sung W. | - |
| dc.contributor.googleauthor | Yu, Sung H. | - |
| dc.contributor.googleauthor | Kwak, Soo H. | - |
| dc.contributor.googleauthor | Park, Kyong S. | - |
| dc.contributor.googleauthor | Lee, Byung Wan | - |
| dc.identifier.doi | 10.1111/dom.14623 | - |
| dc.relation.journalcode | J00722 | - |
| dc.identifier.eissn | 1463-1326 | - |
| dc.subject.keyword | dipeptidyl peptidase-4 inhibitor | - |
| dc.subject.keyword | evogliptin | - |
| dc.subject.keyword | magnetic resonance imaging-derived proton density fat fraction | - |
| dc.subject.keyword | non-alcoholic fatty liver disease | - |
| dc.subject.keyword | pioglitazone | - |
| dc.subject.keyword | type 2 diabetes | - |
| dc.contributor.alternativeName | Lee, Byung Wan | - |
| dc.contributor.affiliatedAuthor | Lee, Byung Wan | - |
| dc.identifier.scopusid | 2-s2.0-85121698174 | - |
| dc.identifier.wosid | 000734621400001 | - |
| dc.citation.volume | 24 | - |
| dc.citation.number | 4 | - |
| dc.citation.startPage | 752 | - |
| dc.citation.endPage | 756 | - |
| dc.identifier.bibliographicCitation | Diabetes, Obesity and Metabolism, Vol.24(4) : 752-756, 2022-04 | - |
| dc.identifier.rimsid | 74007 | - |
| dc.type.rims | ART | - |
| dc.description.journalClass | 1 | - |
| dc.description.journalClass | 1 | - |
| dc.subject.keywordAuthor | dipeptidyl peptidase-4 inhibitor | - |
| dc.subject.keywordAuthor | evogliptin | - |
| dc.subject.keywordAuthor | magnetic resonance imaging-derived proton density fat fraction | - |
| dc.subject.keywordAuthor | non-alcoholic fatty liver disease | - |
| dc.subject.keywordAuthor | pioglitazone | - |
| dc.subject.keywordAuthor | type 2 diabetes | - |
| dc.subject.keywordPlus | SITAGLIPTIN | - |
| dc.subject.keywordPlus | MODEL | - |
| dc.subject.keywordPlus | RISK | - |
| dc.type.docType | Letter | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalWebOfScienceCategory | Endocrinology & Metabolism | - |
| dc.relation.journalResearchArea | Endocrinology & Metabolism | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.